Ritter Ira E. Insider Trades

Insider Trading History

Track insider trading activity for Ritter Ira E.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $128k 40,000 shares
Last Trade
Jul 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.62M 40,000 shares
$240.55
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Director
Holding Value $161k 50,000 shares
Last Trade
Jun 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128M 50,000 shares
$2,565.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Cob, CSO
Holding Value $1.16M 361,502 shares
Last Trade
May 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.89B 361,502 shares
$8,000.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Cob, CSO
Holding Value $262k 81,727 shares
Last Trade
Mar 04, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$105M 18,750 shares
$5,623.75
$3.21
SCWorx
SCWorx WORX
Director
Holding Value $55.5k 50,000 shares
Last Trade
Nov 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.98M 50,000 shares
$39.60
$1.11
SCWorx
SCWorx WORX
Director
Holding Value $55.5k 50,000 shares
Last Trade
Nov 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.98M 50,000 shares
$39.60
$1.11
SCWorx
SCWorx WORX
Director
Holding Value $14.9k 13,393 shares
Last Trade
Feb 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 13,393 shares
$97.35
$1.11
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Cob, CSO
Holding Value $642k 200,000 shares
Last Trade
Feb 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5B 200,000 shares
$7,497.50
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Exec. Chairman, CSO
Holding Value $1.59M 495,065 shares
Last Trade
Jan 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21B 495,065 shares
$42,375.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner, Exec. Chairman, CSO
Holding Value $3.23M 1,004,772 shares
Last Trade
Oct 03, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.1B 375,000 shares
$45,475.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner, Exec. Chairman, CSO
Holding Value $450k 140,044 shares
Last Trade
Oct 25, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.5B 140,044 shares
$325,000.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner, Exec. Chairman, CSO
Holding Value $263k 82,000 shares
Last Trade
Jul 05, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7B 82,000 shares
$191,850.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
10% owner, Exec. Chairman, CSO
Holding Value $20.1k 6,250 shares
Last Trade
Feb 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.24B 6,250 shares
$198,750.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Exec. Chairman, CSO
Holding Value $0 0 shares
Last Trade
Jun 29, 2015 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$451B 817,272 shares
$551,250.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Exec. Chairman, CSO
Holding Value $2.62M 817,272 shares
Last Trade
Jun 29, 2015 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$451B 817,272 shares
$551,250.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Exec. Chairman, CSO
Holding Value $0 0 shares
Last Trade
Jun 24, 2015 Sale
$507B 817,272 shares
$620,000.00
$3.21
Qualigen Therapeutics
Qualigen Therapeutics QLGN
Exec. Chairman, CSO
Holding Value $0 0 shares
Last Trade
Jun 24, 2015 Sale
$311B 502,364 shares
$620,000.00
$3.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up